Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systems

被引:3
作者
Saifeddine, Mahmoud
Seymour, Michelle L.
Xiao, Yu-Pei
Compton, Steven J.
Houle, Steeve
Ramachandran, Rithwik
MacNaughton, Wallace K.
Simonet, Serge
Vayssettes-Courchay, Christine
Verbeuren, Tony J.
Hollenberg, Morley D.
机构
[1] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Endocrine Diabet Grp, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, Fac Med, Inflammat Res Network, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada
[5] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada
[6] Univ Hull, Div Acad Med, Kingston Upon Hull HU6 7RX, N Humberside, England
[7] Inst Rech Servier, Div Angiol, F-92150 Suresnes, France
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 293卷 / 06期
关键词
protease; vascular G protein-coupled receptor;
D O I
10.1152/ajpheart.00519.2007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In canine coronary artery preparations, the proteinase-activated receptor-2 (PAR(2)) activating peptides (PAR(2)-APs) SLIGRL-NH2 and 2-furoyl-LIGRLO-NH2 caused both an endothelium-dependent relaxation and an endothelium- independent contraction. Relaxation was caused at peptide concentrations 10-fold lower than those causing a contractile response. Although trans-cinnamoyl-LIGRLO-NH2, like other PAR(2)-APs, caused relaxation, it was inactive as a contractile agonist and instead antagonized the contractile response to SLIGRL-NH2. RT-PCR-based sequencing of canine PAR(2) revealed a cleavage/activation (indicated by underlines) sequence (SKG (R) under bar/(SLIGKT) under bar DSSLQITGKG) that is very similar to the human PAR(2) sequence ((R) under bar/(SLIGKV) under bar). As a synthetic peptide, the canine PAR-AP (SLIGKT-NH2) was a much less potent agonist than either SLIGRL-NH2 or 2-furoyl-LIGRLO-NH2, either in the coronary contractile assay or in a Madin-Darby canine kidney (MDCK) cell PAR(2) calcium signaling assay. In the MDCK signaling assay, the order of potencies was as follows: 2-furoyl-LIGRLO-NH2 >> SLIGRL-NH2 = trans-cinnamoyl-LIGRLO-NH2 >> SLIGKT-NH2, as expected for PAR2 responses. In the coronary contractile assay, however, the order of potencies was very different: SLIGRL-NH2 >> 2-furoyl-LIGRLO-NH2 >> SLIGKT-NH2, trans-cinnamoyl-LIGRLO-NH2 = antagonist. Because of 1) the distinct agonist (relaxant) and antagonist (contractile) activity of trans-cinnamoyl-LIGRLO-NH2 in the canine coronary contractile assays, 2) the different concentration ranges over which the peptides caused either relaxation or contraction in the same coronary preparation, and 3) the markedly distinct structure-activity profiles for the PAR-APs in the coronary contractile assay, compared with those for PAR(2)-mediated MDCK cell calcium signaling, we suggest that the canine coronary tissue possesses a receptor system for the PAR-APs that is distinct from PAR2 itself.
引用
收藏
页码:H3279 / H3289
页数:11
相关论文
共 38 条
[1]   Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea [J].
Abey, HT ;
Fairlie, DP ;
Moffatt, JD ;
Balzary, RW ;
Cocks, TM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02) :598-605
[2]   A STUDY OF THE ADRENOTROPIC RECEPTORS [J].
AHLQUIST, RP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1948, 153 (03) :586-600
[3]   Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells [J].
Al-Ani, B ;
Hollenberg, MD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03) :1120-1128
[4]   DETECTION OF FUNCTIONAL RECEPTORS FOR THE PROTEINASE-ACTIVATED-RECEPTOR-2-ACTIVATING POLYPEPTIDE, SLIGRL-NH2, IN RAT VASCULAR AND GASTRIC SMOOTH-MUSCLE [J].
ALANI, B ;
SAIFEDDINE, M ;
HOLLENBERG, MD .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (08) :1203-1207
[5]  
BOHN SK, 1996, BIOCHEM J, V314, P1009
[6]   Protease-activated receptors in hemostasis, thrombosis and vascular biology [J].
Coughlin, SR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) :1800-1814
[7]  
Damiano BP, 1996, J PHARMACOL EXP THER, V279, P1365
[8]  
DEMEY JG, 1982, J PHARMACOL EXP THER, V222, P166
[9]   Direct and series transmission of left atrial pressure perturbations to the pulmonary artery: a study using wave-intensity analysis [J].
Hollander, EH ;
Dobson, GM ;
Wang, JJ ;
Parker, KH ;
Tyberg, JV .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (01) :H267-H275
[10]   Proteinase-activated receptor-4:: Evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo [J].
Hollenberg, MD ;
Saifeddine, M ;
Sandhu, S ;
Houle, S ;
Vergnolle, N .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (04) :443-454